Skip to main content
. 2017 Aug 2;14(6):1248–1257. doi: 10.1111/iwj.12791

Figure 2.

IWJ-12791-FIG-0002-c

Reduction of Pseudomonas aeruginosa cfu observed in different treatment groups on various treatment days (5, 7, 11). *P < 0·05 compared with CSM‐FPEG, CSM and Tegaderm™ control groups; ▴P < 0·05 compared with CSM‐FPEG, SSD‐CSM, CSM and Tegaderm control groups; ‡P < 0·05 compared with Tegaderm control; †P < 0·05 compared with all other five treatment groups.